Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.01 (-0.86%)
Close on Nov 16, 2026Market cap $103.34MP/E –Yield –
Organogenesis profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Organogenesis's profit margin for the twelve months ending Jun 30, 2026 was -18.4%. For fiscal 2025 it was 6.6%, against 0.2% the year before. The highest annual figure on record is 20.2% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.6% | +6.4 |
| FY2024 | Dec 31, 2024 | 0.2% | −1.0 |
| FY2023 | Dec 31, 2023 | 1.1% | −2.3 |
| FY2022 | Dec 31, 2022 | 3.4% | −16.7 |
| FY2021 | Dec 31, 2021 | 20.2% | +15.1 |
| FY2020 | Dec 31, 2020 | 5.1% | +19.9 |
| FY2019 | Dec 31, 2019 | -14.8% | +18.7 |
| FY2018 | Dec 31, 2018 | -33.5% | −29.3 |
| FY2017 | Dec 31, 2017 | -4.2% | +8.0 |
| FY2016 | Dec 31, 2016 | -12.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -220.0% | −210.7 |
| Q1 FY2026 | Mar 31, 2026 | -142.8% | −121.0 |
| Q4 FY2025 | Dec 31, 2025 | 19.4% | +13.3 |
| Q3 FY2025 | Sep 30, 2025 | 14.3% | +3.6 |
| Q2 FY2025 | Jun 30, 2025 | -9.3% | +3.8 |
| Q1 FY2025 | Mar 31, 2025 | -21.7% | −19.8 |
| Q4 FY2024 | Dec 31, 2024 | 6.1% | +6.6 |
| Q3 FY2024 | Sep 30, 2024 | 10.7% | +7.8 |
| Q2 FY2024 | Jun 30, 2024 | -13.1% | −17.6 |
| Q1 FY2024 | Mar 31, 2024 | -1.9% | +0.8 |
| Q4 FY2023 | Dec 31, 2023 | -0.6% | −7.1 |
| Q3 FY2023 | Sep 30, 2023 | 2.9% | +2.7 |
| Q2 FY2023 | Jun 30, 2023 | 4.5% | −2.7 |
| Q1 FY2023 | Mar 31, 2023 | -2.8% | −1.8 |
| Q4 FY2022 | Dec 31, 2022 | 6.5% | −33.4 |
| Q3 FY2022 | Sep 30, 2022 | 0.2% | −10.9 |
| Q2 FY2022 | Jun 30, 2022 | 7.2% | −9.6 |
| Q1 FY2022 | Mar 31, 2022 | -0.9% | −10.6 |
| Q4 FY2021 | Dec 31, 2021 | 39.9% | +22.7 |
| Q3 FY2021 | Sep 30, 2021 | 11.1% | −9.5 |
| Q2 FY2021 | Jun 30, 2021 | 16.8% | +24.3 |
| Q1 FY2021 | Mar 31, 2021 | 9.7% | +36.1 |
| Q4 FY2020 | Dec 31, 2020 | 17.1% | +20.7 |
| Q3 FY2020 | Sep 30, 2020 | 20.6% | +37.3 |
| Q2 FY2020 | Jun 30, 2020 | -7.5% | +7.4 |
| Q1 FY2020 | Mar 31, 2020 | -26.4% | +1.0 |
| Q4 FY2019 | Dec 31, 2019 | -3.6% | +11.0 |
| Q3 FY2019 | Sep 30, 2019 | -16.7% | +9.0 |
| Q2 FY2019 | Jun 30, 2019 | -14.9% | +31.1 |
| Q1 FY2019 | Mar 31, 2019 | -27.4% | +35.9 |
| Q4 FY2018 | Dec 31, 2018 | -14.6% | −6.2 |
| Q3 FY2018 | Sep 30, 2018 | -25.8% | −15.3 |
| Q2 FY2018 | Jun 30, 2018 | -45.9% | −46.0 |
| Q1 FY2018 | Mar 31, 2018 | -63.3% | −69.0 |
| Q4 FY2017 | Dec 31, 2017 | -8.3% | −8.2 |
| Q3 FY2017 | Sep 30, 2017 | -10.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 0.1% | – |
| Q1 FY2017 | Mar 31, 2017 | 5.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -0.1% | – |
See a number that looks wrong?